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Summary
Osteoporosis and other pathological bone conditions can impair bone regeneration properties, consuming in increased morbidity 
and decreased quality of life. Changes of bone healing can result in poor osteointegration and surgical failures if implants are 
used. To overcome and facilitate bone regeneration, more attempts are made to develop an ideal synthetic scaffold with better 
biocompatibility, osteoconductivity, bioactivity, osteoinductivity and interconnected porosity. It is considered that strontium, being 
similar to calcium, can be incorporated into the mineral phase of the bone remodeling. This quality had led strontium to be used as 
an osteoporotic medication to improve quality of bone and to reduce the risk of bone fractures. Also local application of strontium 
has been widely used within different biomaterials in tissue engineering researches. 
In this review authors wanted to provide an overview about strontium, its mechanisms of action in bone tissue and initiated changes 
of bone remodeling within biomaterials.
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INTRODUCTION
Bone regeneration, provided by osteoblasts and 
osteoclasts, is influenced by complicated cross talk 
between the immune and skeletal systems, being 
regulated by many molecules like cytokines, growth 
factors, different receptors and transcriptional factors 
(46). When physiological process of bone metabolism 
is disrupted, weather by the disease or for experimental 
purposes, disbalance of normal bone turnover 
occurs. Osteoporosis being one of the most common 
musculoskeletal bone pathologies is characterized as 
a chronic age related disease with compromised bone 
strength (49). It affects one in three women and one in 
five men worldwide and can present with low energy 
trauma induced skeletal fractures leading to morbidity 
and changes in quality of life (45). 
Strontium (Sr) is an alkaline earth metal with an 
atomic number 38 (31).  Sr can be incorporated into 
the mineral phase of the bone remodeling due to the 
similarity to calcium ions (1). Strontium has shown 
dual action properties – it increases bone formation 
and decreases bone resorption, leading to a new bone 
formation, improved quality of bone micro architecture 
and strength (21). Thereby, strontium ranelate (SR) 
as anti-osteoporotic medication was first registered 
in Europe in 2004 and was indicated for women with 
postmenopausal osteoporosis to reduce the risk of 
vertebral and hip fractures (43). Effectiveness of SR to 
prevent osteoporosis and reduce the risk of fractures is 
well demonstrated in large clinical trials (42), like The 
SOTI (Spinal Osteoporosis Therapeutic Intervention) trial, 
where SR increased bone mineral density, improved 
quality of life and reduced the risk of vertebral fractures 
by 33% (28) and the TROPOS (Treatment of Peripheral 
Osteoporosis) trial, where the risk of vertebral fractures 
was reduced by 43% but nonvertebral and hip fractures 
by 15% and 24% respectively (41). Moreover, SEKOIA 
(Strontium Ranelate Efficacy in Knee Osteoarthritis 
Trial) trial showed that administration of SR for 2g/
day over 3 years is associated with a significant 
improvement in pain, physical activities and stiffness. 
Reduction of cartilage volume loss and bone marrow 
lesions were found on MRI in participants of SEKOIA 
trial (35). Unfortunately, systematic treatment with 
SR is associated with some adverse effects including 
headache, diarrhea, nausea and, rarely, cutaneous 
hypersensitivity (42). There is still ongoing discussion 
whether it increases life threatening cardiac events and 
venous thrombosis (6, 12).
The recognition of positive effects of strontium on bone 
tissue in different in vitro and in vivo studies, has led to its 
local application in variety of biomaterials, used in tissue 
engineering for better bone repair and regeneration 
(51). Long term local and targeted release of Sr ions 
from biomaterial or implant to surrounding bone tissue 
interface is considered as a good option to increase 
osseointegration of implant and to avoid adverse effects 
due to the oral administration of Sr (26).
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Strontium
Strontium is an alkaline earth metal with an atomic 
number 38 and is mostly found in ocean water, 
nutritional supplements and food, like grains or seafood. 
Very small amount of Sr is up-taken through skin and 
lungs (31). In our body 99% of total amount of Sr is 
incorporated in the structure of new trabecular bone, 
close together connected to bone native hydroxyapatite 
(11). These features have led strontium attractive for 
medical applications. The similarity between Sr and 
calcium enables Sr to be incorporated into the mineral 
phase of the bone (1). It is calculated, that the amount 
of Sr in new compact bone is 3-4 folds higher than in old 
compact bone and 2-3 folds higher in new cancellous 
bone than in old one (27) due to higher bone turnover 
in cancellous than cortical bone (54). However, the total 
amount of Sr is noticeably smaller than calcium and 
reaches only 3.5% of the content of calcium found in 
our body (5).  
Strontium ion interaction on bone cells
The role of strontium in bone mineralization 
and remodeling is increasing and new insights of 
morphopathogenetical mechanisms are found. Multiple 
intracellular signaling pathways are involved in 
strontium interaction on bone forming cells through 
different activated molecules, which promote their 
survival, proliferation and differentiation (51). It 
promotes an increase of formation of the mineralized 
matrix in osteoblast cell cultures, which are similar to 
the composition of native bone tissue (39).
Strontium and osteoblasts
During the treatment of strontium, multiple osteogenic 
genes can be prepossessed. For example, Runx2 
(Runt-related transcriptional factor 2) is up-regulated 
through Sr ability to activate MAPK (mitogen activated 
protein kinase) phosphorylation in osteoblasts, 
initiating osteogenic differentiation (36). Due to the 
similarity between strontium and calcium ions, Sr 
can act on osteoblasts through the calcium sensing 
receptors (CaSR), activating cell replication via MAPK 
signaling, (37) Another Sr induced pathway through 
CaSR is activating ERK1/2 (extracellular signal related 
kinase) signaling pathways and osteoblast replication. 
Importantly, it was found that Sr activates Akt (protein 
kinase) pathway, mediating anti-apoptotic effect on 
osteoblasts (16). One more positive effect of Sr have 
been found by Rybchyn et al., where Sr decreased the 
expression of sclerostin, an inhibitor of the canonical Wnt 
(wingless-related integration site) signaling pathway, 
promoting β-catenin translocation into the nucleus of 
human osteoblasts and promoting osteogenesis (47). 
Others have found that Sr induces osteoblastic cell 
replication and differentiation via activating NFATc1 
mediated canonical and non-canonical Wnt signaling 
pathways. NFATc1 (nuclear factor of activated T cells) 
are important transcription factor which regulates 
targeted genes in bone, increasing osteoblast replication 
and functions (15). Sr also enhances the release of 
different signaling molecules involved in regulation of 
bone turnover by mechanically stimulated osteocytes 
(3). In vitro study by Caverzasio et al., showed another 
mechanism of Sr and indicated that Sr can activate the 
FGF/FGFR (fibroblast growth factor receptor) pathway 
enhancing osteoblast growth (7).
Strontium and osteoclasts
Furthermore, strontium has positive effect on bone 
remodeling by inhibiting osteoclastogenesis and 
bone resorption (4). Sr stimulates expression of 
osteoprotegerin (OPG), a member of tumor necrosis 
factor superfamily, which plays important role in the 
regulation of bone metabolism through OPG/RANK/
RANKL mechanism, decreasing the expression of 
RANKL (receptor activated nuclear factor kappa ligand) 
thus inhibiting osteoclast differentiation and function 
(2). Bakker et al., found that Sr can also affect mature 
osteoclasts and induce their apoptosis through calcium 
sensing receptors (3).
Strontium and adipocytes
Adipogenesis also plays an important role in pathogenesis 
and progress of osteoporosis. Strontium has shown the 
ability to inhibit differentiation of adipocytes from bone 
marrow mesenchymal stem cells and increase osteoblast 
differentiation (24). This is because of strontium ability 
to inhibit PPARγ2 (peroxisome proliferator activated 
receptor gamma2) adipocyte transcription factor and 
decreasing replication of adipocyte (10, 48). 
Strontium and biomaterials
Many studies have been investigating Sr effects in 
different biomaterials and results are encouraging. 
Strontium ions are being incorporated in different 
biomaterials and metallic implants like synthetic 
hydroxyapatites, glass ceramics, bioactive glasses, 
calcium phosphate cements or metallic implants 
with different alloys, searching for increased bone 
quality and formation in bone tissue defects or around 
osseointegrating implants (22, 25, 29, 33, 52). In recent 
years there is a development of injectable materials for 
filling bone defects as minimally invasive techniques. 
Also strontium rich injectable hybrid systems have been 
developed with promising results in tissue engineering 
(29). An ideal bone substitutive scaffold should induce 
and restore biological functions of bone matrix, where 
cells and growth factors are needed, but also have 
the right properties with respect to degradation, cell 
binding, cellular uptake, non-immunogenicity, strength 
and flexibility (4). 
Expression changes of bone biomarkers
Multiple in vivo and in vitro studies have shown, that Sr 
doped biomaterials can stimulate osteoblast proliferation 
and differentiation to form a new bone (38). Changes 
of bone turnover is seen in expression levels of bone 
biomarkers. It is found, that Sr increase higher collagen 
synthesis and enriche precipitation of hydroxyapatite 
(30). It up-regulates higher expression of alkaline 
ACTA CHIRURGICA LATVIENSIS • 2016 (16/2)
19
phosphatase (APL), collagen type I (Col I) and OPG in 
animals (32). Singh et al., have found, that Sr doped 
biomaterials can increase expression of osteocalcin and 
osteopontin, both required for matrix mineralization 
(50). Sr is also capable of enhancing expression of 
BMP2 (bone morphogenic protein 2) through Wnt 
and MAPK signaling pathways by activating CaSRs 
(49). Yang et al., compared hydroxyapatite with and 
without Sr and found out that it induces proliferation 
and differentiation of osteoblasts through higher 
transcriptional activity of Wnt signaling and β-catenin 
expression (55).  Strontium loaded xerogel scaffolds 
were used to treat critical size metaphyseal fracture 
defects in ovariectomized rats, where Sr group scaffolds 
resulted in significantly higher bone formation, higher 
intensity of BMP2, OPG, Col I, Runx2, osteocalcin (OC) 
and lower expression of RANKL (40). Similar results 
were published by Isaac et al., where mouse calvarial 
bone cell model was enriched with Sr containing 
bioactive glass material. They found enhanced osteoblast 
proliferation, greater activity of APL, higher secretion of 
osteocalcin, Col-I, bone sialoprotein and up-regulation 
of Runx2 and Osterix genes (22). Also Park et al., 
demonstrated that strontium modified ceramic bone 
graft substitute showed early osteoblast differentiation. 
ALP activity, OC, transcriptional factors like Runx2 and 
Osterix was found to be upregulated comparing with 
other samples without Sr (33). Moreover, presence of 
Sr ions can interact and down regulate release of pro-
inflammatory cytokine like TNF-α (tumor necrosis 
factor α) and IL-1 (interleukin 1) (14). In vitro study 
of periodontal ligament cells showed that Sr is able 
to inhibit expression of IL-6, which plays important 
role in inflammation and osteoclastogenesis by up-
regulating expression of RANKL and inducing bone 
resorption (44). Sr can also inhibit MMP2 and MMP9 
(matrices metalloproteinase), which are involved in 
the process of tissue degradation (34). Andersen et al., 
found correlation between OPG and presence of CD68 
on osteoclasts - when expression of OPG was increased, 
the expression of CD68 was absent, indicating that 
recruitment of osteoclast precursors are limited near the 
implants containing Sr (1). 
Induction of angiogenesis
Strontium can stimulate neoangiogenesis, promoting 
proliferation and migration of endothelial cells (8). 
Similarly, it was found that calcium phosphate scaffolds 
containing Sr induced the secretion of proangiogenic 
factors as bFGF (basic fibroblast growth factor) and 
VEGF (Vascular endothelial growth factor). VEGF is 
an important regulator in neoangiogenesis and its 
expression is upregulated during the fracture repair 
to induce development of new blood vessels, whereas 
bFGF plays a pivotal role in fracture healing and 
bone remodeling. It may accelerate proliferation and 
differentiation of osteoblastic cell lineage and stimulate 
VEGF release from osteoblasts. This indicates that 
Sr promotes neovascularization and improves new 
bone formation (17). Chen et al., used biodegradable 
strontium doped calcium polyphospshate (CPP) to 
promote the adhesion and spread of endothelial cells. 
They obtained that proliferation of endothelial cells 
and number of migrating cells to form new blood 
vessels showed superior results compared to CPP group 
without strontium ions (9). Similar results were found 
using different biomaterials. Macroporus strontium 
substituted calcium silicate bioactive ceramic scaffold 
was used on osteoporotic bone regeneration for critical 
rat calvarial bone defect model repair. Results showed, 
that Sr plus group enhanced early and prolonged 
expression of VEGF (25).
Local effect of strontium on cells
Many cytocompatibility studies has been done to 
evaluate local and side effect of biomaterials containing 
strontium ions. Tie et al., has carried out detailed study 
on rabbits, where they compared pure magnesium, 
which was previously considered as a biocompatible 
and non-toxic implant material with Sr containing 
magnesium alloy. Hemolysis was found to be almost 
3 folds higher in magnesium group for 7.13%, but 
Sr group showed only 2.54%. They also investigated 
influence of Sr on peri-implant localized toxicity and 
systematic toxicity of rabbits’ spleen, kidney and liver. 
No morphological changes of nuclei of vastus lateralis 
muscle were found. There were no signs of necrotic 
tissue at all. Also no changes or inflammatory infiltrates 
were found in liver, spleen or kidney (52). Similar 
findings were stated by many other authors. Sr rich novel 
bioresorbable hydroxyapatite membrane biomaterial 
showed better bone regenerative properties and no 
cytotoxicity of surrounding tissue (20). Even more, Sr 
doped biomaterials can enhance bone cell viability in 
the process of healing (25) or calcium phosphate doped 
with strontium can increase the number of live cells in 
comparison to calcium phosphate alone (51).  Gu et al 
have demonstrated, that incorporation of strontium in 
magnesium –zirconia implants, used for rabbit femur 
defects, influences osteogenesis by superior viability 
and proliferation of osteoblasts on implant surfaces. No 
adverse tissue reaction and no cytotoxic effect at various 
points of time using Sr was determinate (18).
Bone volume and strength changes
Querido et al., concluded that presence of Sr 
improves the interaction of osteoblastic cells with 
titanium substrates, increasing cell proliferation and 
differentiation into mature osteoblasts and production 
of bone-like mineralized matrix (39). Biocompatibility 
testing of Sr modified titanium implant was carried 
out by Liu et al., where they found, that adding Sr 
ions can improve spreading of osteoblasts, increase 
early adherent cell number and enhance osteoblasts 
growth through significantly enhanced expression of 
osteogenesis related genes and proteins on implant 
surface area (26). Presence of Sr also shows better bone 
to implant contact when compared to control groups 
(52) or a larger amount of new bone in the marrow 
space close to implant (1). Incorporation of strontium 
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into the hydroxyapatite gel forming system resulted in 
effective vertical bone expansion for rat calvarial bone 
augmentation compared with control group without Sr. 
It was demonstrated that single injection of new system 
may activate the progenitor cells from periosteum to 
increase healing time and enhance bone augmentation 
(20). Another study compared different bone substitutes 
for bone defects in trabecular region of rats’ femur. 
Superior results of total amount of new bone formation 
using Sr containing hydroxyapatites (HA) was found 
rather than in Sr negative group. They obtained, that 
SrHA promotes early bone regeneration, involving 
reduced number of osteoclasts and downregulation of 
osteoclastic genes like CatK (osteoclast activity marker) 
and CR (osteoclasts receptor marker) and reduction of 
RANKL expression. Also IL-6 and TNF – α expression 
levels were significantly reduced in bone defects filled 
with SrHA (13). When added to calcium phosphate 
cement material, Sr showed accelerated degradation 
and enhanced osteoconductivity with higher rate 
of cell proliferation and new bone formation. Also 
significantly more peri-cement area of new bone and 
less cement residues were observed 32 weeks after the 
rat femur bone defect operation (23). Use of strontium 
modified calcium phosphate cement in critical-size 
metaphyseal fracture defects in ovariectomized rats 
showed statistically significant amount of enhanced 
new bone formation in the entire defect area compared 
to control groups. High rates of Sr were detected up to 
a distance of 6mm to the implant, proving that local 
delivery of strontium stimulates new bone formation 
(53). Sr enriched scaffolds improves implant bone 
apposition during bone formation with very little or 
no discontinuity between them (18). Another positive 
effects of Sr show that addition of strontium increases 
the resistance of corrosion in different scaffolds and 
improves mechanical properties of bone (19).
Preliminary study done by authors 
Authors is conducting in vivo study of osteoporotic rabbit 
femur bone defect substitution with strontium and 
without strontium enriched biomaterials. Contralateral 
intact femur bone was set as a control. Obtained data 
were compared between healthy rabbits’ bone and 
sham surgery affected bone to exclude traumatic role 
for bone regeneration. Results showed that number 
of osteoprotegerin positive cells is up-regulated when 
strontium within biomaterial is used, while traumatic 
injury and biomaterials without strontium marked 
notable lesser number of cells (Table 1) (Pilmane and 
Zarins, unpublished data, 2016). The osteoporotic bone 
alone demonstrated just few osteoprotegerin positive 
cells (Figure 1-3). 
CONCLUSION
Strontium enriched biomaterials shows superior results 
to induce osteogenesis and new bone formation up-
regulating expression of biomarkers like osteoprotegerin, 
alkaline phosphatase, osteopontin, osteocalcin and 
VEGF in comparison to others without strontium. 
Even more, presence of strontium can decrease 
osteoclastogenesis and bone resorption, showing no 
cytotoxic effect on viable bone cells.  Although use 
of strontium in different biomaterials have shown 
encouraging results, there is still not fully understood 
mechanisms of action. Moreover, Sr effects are dose 
dependent and exact dose is not established yet. There 
is need for further studies to provide new and precise 
insights into the pathophysiology of bone regeneration.
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Table 1. Comparison of osteoprotegerin containing cells between osteoporosis affected bone and such 





Sham surgery Osteoporotic bone
Number of 
rabbits
7 7 4 2
OPG + + + + + + + +
Number of immunopositive cells were evaluated by semiquantitative method, where “+” – few positive structures in 
visual field; “++” – moderate positive structures in visual field; “+++” – numerous positive structures of visual field. 
Fig. 1. Note numerous osteoprotegerin - 
containing osteocytes in osteoporotic rabbit bone 
after biomaterial and strontium implants. OPG 
IMH, x 150
Fig. 3. Note few osteoprotegerin - containing 
positive osteocytes in osteoporotic rabbit bone. 
OPG IMH, x 200
Fig. 2. Note moderate osteoprotegerin - containing 
positive cells in osteoporotic sham surgery bone. 
OPG IMH, x 200
